eyeMO (NASA High-Res OCT)

About Kubota Vision

Kubota Vision is a clinical-stage biotech focused on ophthalmic diseases, advancing a hybrid pipeline of small molecule therapeutics and novel medical devices. Its lead asset is emixustat HCl, in development for Stargardt disease and proliferative diabetic retinopathy, while its device portfolio includes the Kubota Glass for myopia control and remote retinal monitoring systems. The company leverages its position within the Kubota Pharma Group to pursue a dual strategy of treating retinal diseases and managing common refractive errors with high-tech solutions.

Therapeutic Areas

Other Remote Retinal Monitoring Drugs